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Sarcoidosis is a mysterious, long-recognized 
disease characterized by the formation of 
tuberculosis-like granulomas in the lungs. The 
mystery of sarcoidosis stems from both its 
unknown etiology and its paradoxical effects 
on the immune system. The disease has been 
attributed to a hyperactivation of CD4
+ T 
helper type 1 cells that infiltrate the lungs but, 
in patients with sarcoidosis, these very cells fail 
to proliferate in response to recall antigens.
On   page 359  , Miyara and colleagues sug-
gest that half-cocked regulatory T (T reg) cells 
that inhibit proliferation by T cells but not 
their cytokine production might be to blame 
for this immune contradiction.
T reg cells normally help suppress chronic 
inflammation by inhibiting both effector T cell 
proliferation and cytokine production. Miyara 
et al. now show that although T reg cell num-
bers are elevated in both the blood and the 
lungs of patients with sarcoidosis, these cells 
were unable to curb the CD4
+ T cell produc-
tion of TNF and interferon (IFN)-γ—inflam-
matory cytokines that drive the formation and 
maintenance of granulomas. However, the 
patients’ T reg cells could still shut down effector 
T cell proliferation, possibly explaining the 
inability of T cells to respond to recall antigens.
The mechanism behind the T reg cell 
defect in patients with sarcoidosis remains to 
be defined, but might be a byproduct of 
chronic inflammation, as half-active T reg 
cells have also been found in autoimmune 
inflammatory diseases such as rheumatoid 
arthritis and multiple sclerosis. 
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Allergen-induced activation of mast cells—which triggers the rapid release of 
histamine-containing granules and the slower synthesis of inflammatory 
cytokines—is often thought to be an all-or-none process. Not so, say Klemm 
and colleagues (  page 337  ), who identify two adaptor proteins that are required 
for cytokine production by mast cells but are dispensable for degranulation.
The adaptor molecules in question—Malt1 and Bcl10—are required 
for the activation of the transcription factor NF-κB in T and B cells. But 
a role for these adaptors in mast cells had never been addressed. Klemm 
et al. now show that mice lacking either Malt1 or Bcl10 failed to develop 
late-phase anaphylactic responses, which depend on the production of 
NF-κB–dependent cytokines. By contrast, acute anaphylaxis—which is 
driven by mast cell degranulation—was normal in the deficient mice.
Whether physiological situations exist in which mast cells degranulate 
without producing cytokines is unknown. But the discovery of adaptors 
that uncouple these signaling pathways might provide a way to block the 
production of mast cell-derived cytokines, which perpetuate inflammatory 
diseases such as chronic severe asthma, without hindering degranulation.
Although the advantages of leaving degranulation intact might not 
be obvious, especially to those who sneeze their way through hay fever 
season, this process has benefits. One benefit is protection against the 
damaging side effects of endothelin-1, a potentially harmful vasoactive 
peptide that is produced by endothelial cells in response to stress and is 
degraded by mast cell proteases. 
Regulatory T cells (red), shown in a sarcoidosis 
granuloma, inhibit T cell proliferation, but not 
their cytokine production.
NK cell inhibitory receptor KLRG1 
(blue) binds to cadherins (purple) 
on target cells.
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Natural killer (NK) cells get turned off by cadherins, according to a study on 
  page 289  . Ito and colleagues identify E-cadherin as a binding partner for the 
once-orphan inhibitory NK cell receptor KLRG1.
NK cells must integrate both positive and negative signals—delivered by 
a variety of activating and inhibitory receptors on their cell surface—to 
determine whether a target cell should be attacked. Many NK cell inhibitory 
receptors, including Ly49 receptors (mice) and killer cell immunoglobulin-
like receptors (humans), bind to MHC class I molecules on target cells. This 
allows NK cells to distinguish between normal cells, which express class I 
molecules, and abnormal cells, which often lack these proteins due to 
transformation or viral infection. The binding partners for other inhibitory 
receptors, including KLRG1, had not been identified.
Ito and colleagues now show that KLRG1 pairs up with cadherins (E-, N- 
and R-cadherin)—adhesion molecules that help form junctions between 
epithelial and endothelial cells. When the pairing of NK cells and target cells 
occurs via cadherins, they show, NK cell-mediated killing is inhibited.
Why would NK cells express receptors for 
adhesion proteins that are normally concealed 
in cell–cell junctions? One possibility is to 
promote surveillance of improperly 
detached cells. These cells, including 
many tumor cells, have reduced 
E-cadherin expression, allowing them to 
sever ties with adjacent cells. But 
without E-cadherin, tumor cells can no 
longer send inhibitory signals through 
KLRG1, possibly making them more 
prone to NK cell attack. 